Overall rates of cancer and cancer mortality in the United States continue to decline, according to the Annual Report to the Nation on the Status of Cancer.
Retinoblastoma (Rb) survivors have increased risk of chronic conditions, according to a study published in the March 1 issue of Cancer.
In a study of more than 1.1 million cancer patients who had surgery, Harvard researchers found that almost 5% died within one month of their operation.
About 14.5 million U.S. cancer survivors are alive today, compared to just three million in 1971, with prevention and targeted therapies helping to reduce mortality.
A medical practice in KY has pleaded guilty to federal charges regarding the purchasing and selling of unapproved and improperly labeled chemotherapy drugs.
The risk for certain types of cancer seems to be linked to poverty or wealth and socioeconomic status should be considered in cancer surveillance.
For patients undergoing radiotherapy, shared decision-making and patient-perceived control in treatment decisions correlate with increased patient satisfaction.
By age 50 years, more than half of childhood cancer survivors have experienced a severe, disabling, life-threatening, or fatal health condition.
About one-third of U.S. oncologists report being satisfied with work-life balance (WLB), which is lower than for other medical specialties.
Experts have identified three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging, and drug pricing.
Terminally ill patients with cancer who receive chemotherapy at the end of life are at increased risk of dying in an ICU and receiving CPR and/or mechanical ventilation.
The USPSTF has found that insufficient evidence to evaluate the benefits and harms of multivitamins and most single- or paired-nutrient supplements for the prevention of cardiovascular disease and cancer.
Recommendations relating to the key elements of minimum adequate cancer family history are detailed, although they are often incompletely implemented.
Although significant progress has been made in treating cancer, >1.6 million Americans are projected to receive a cancer diagnosis in 2013.
Increased exposure to air pollution during pregnancy and the first year of life is associated with an increased risk of pediatric acute lymphoblastic leukemia, germ cell tumors, and retinoblastoma.
Risk classification based on histopathologic features is an effective approach to selecting appropriate adjuvant therapy for patients with intraocular unilateral retinoblastoma treated by primary enucleation.
Fewer Medicare beneficiaries are dying in the setting of acute care hospitals, but health care transitions and intensive care unit (ICU) utilization are increasing in the last month of life.
Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer and neutropenia who are at low risk of complications.
Oncology patients with lower income, even older patients with access to Medicare, are significantly less likely to participate in clinical trials.